You are viewing a javascript disabled version of the site. Please enable JavaScript for this site to function properly.
Go to navigationGo to searchGo to contents
Go to chapter navigation
Figure 18.1
The fingertip unit.
Figure 18.5
Periocular dermatitis.
Figure 18.9
Circumlesional scaling characteristic of psoriasis lesions treated with vitamin D analogues.
Figure 18.13
(a) Staining of the skin due to dithranol treatment. (b) An irritant reaction following accidental contamination of normal skin with dithranol.
Figure 18.2
Configuration of the basic corticosteroid structure.
Figure 18.6
Structures of tacrolimus and pimecrolimus.
Figure 18.10
Cutaneous atrophy and striae in a 21‐year‐old man from the unsupervised use of calcipotriol and betamethasone ointment 60 g weekly for 2 years.
Figure 18.3
(a, b) Permanent atrophy induced by repeated use of clobetasol propionate for psoriasis.
Figure 18.7
Structures of retinoid molecules used topically.
Figure 18.11
Crude coal tar in white soft paraffin – a rather messy and inconvenient treatment.
Figure 18.4
Tinea incognita. (a) Signs of tinea manus are partly suppressed by treatment with a potent topical steroid. (b) Rash on a foot extending progressively...
Figure 18.8
Structures of calcitriol, tacalcitol, calcipotriol and maxacalcitol.
Figure 18.12
Structure of dithranol.